Skip to content

13F-HR filed by Caligan Partners LP

Caligan Partners LP filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 11 holding rows worth $296,522,630.

Accession
0001727492-24-000002
Filed
2024-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2023

A holdings report, 11 entries on the cover page, a total value of $296,522,630 stated on the cover page (in dollars after the unit check, H1), rows summing to $296,522,630 with VALUE read as dollars as filed, 13F file number 028-23096. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
LIQUIDIA CORPORATION COM NEW53635D202Stock10,360,945$124,642,168dollars as filed
ALIMERA SCIENCES INC016259202COM16,835,154$72,727,865dollars as filed
ANIKA THERAPEUTICS INC035255108COM1,081,360$24,503,618dollars as filed
EXELIXIS INC COM30161Q104Stock910,730$21,848,413dollars as filed
STANDARD BIOTOOLS INC34385P108COM7,042,413$15,563,733dollars as filed
EVOLUS INC30052C107COM1,317,856$13,877,024dollars as filed
AGIOS PHARMACEUTICALS INC00847X104COM441,833$9,839,621dollars as filed
Y-mAbs Therapeutics Inc984241109Common Stock1,048,425$7,150,259dollars as filed
VERONA PHARMA PLC925050106SPONSORED ADS183,064$3,639,312dollars as filed
ADMA BIOLOGICS INC000899104COM473,087$2,138,353dollars as filed
SOCIETAL CDMO INC75629F109COM1,689,768$592,264dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001727492-24-000002this filing2024-02-14acceptance time not in the bulk data set